Treasury Chief Rachel Reeves Aims for Focused Action on Bills in Upcoming Financial Plan
Treasury head Rachel Reeves has announced she is preparing "targeted action to tackle cost of living challenges" in the upcoming financial statement.
During an interview with the BBC, she noted that reducing inflation is a shared responsibility of both the government and the Bank of England.
The United Kingdom's inflation rate is projected to be the most elevated among the Group of Seven developed nations this calendar year and next.
Possible Energy Bill Interventions
Sources suggest the government could take action to reduce utility costs, for instance by reducing the present 5% rate of VAT charged on energy.
An additional possibility is to cut some of the regulatory levies presently included in bills.
Budgetary Constraints and Analyst Expectations
The administration will receive the next assessment from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much room there is for such measures.
The expectation from the majority of analysts is that the Chancellor will have to declare higher taxes or budget cuts in order to adhere to her voluntary fiscal targets.
Previously on the same day, calculations showed there was a ÂŁ22bn gap for the Treasury chief to address, which is at the more modest range of expectations.
"It is a collective task between the central bank and the government to further reduce some of the sources of price increases," the Chancellor stated to reporters in Washington, at the yearly gatherings of the International Monetary Fund and World Bank.
Revenue Pledges and Global Issues
While much of the attention has been on likely tax rises, the Treasury chief said the most recent data from the OBR had not altered her pledge to campaign commitments not to raise tax levels on earnings tax, sales tax or National Insurance.
She blamed an "unpredictable global environment" with rising international and commercial tensions for the Budget revenue measures, probably to be focused on those "wealthiest."
Global Trade Disputes
Addressing concerns about the United Kingdom's commercial links with the Asian nation she said: "Our security interests invariably come first."
Last week's statement by China to increase export controls on rare earths and other resources that are essential for high-technology production led US President the US President to propose an extra 100% tariff on imports from the Asian country, raising the risk of an full-scale commercial conflict between the two economic giants.
The US Treasury Secretary called China's action "economic coercion" and "a global supply chain power grab."
Asked about considering the US offer to participate in its battle with China, Reeves said she was "extremely troubled" by Chinese measures and urged the Chinese government "to avoid restrictions and limit trade."
She said the action was "bad for the global economy and creates further headwinds."
"In my view there are areas where we must confront Chinese policies, but there are also significant chances to trade with Chinese markets, including financial services and other sectors of the economic system. We've got to get that equilibrium right."
The Treasury chief also stated she was cooperating with G7 counterparts "regarding our own critical minerals plan, so that we are reduced dependence."
NHS Drug Costs and Investment
The Chancellor also recognized that the price the National Health Service spends on pharmaceuticals could increase as a result of ongoing talks with the US government and its drugs companies, in return for reduced taxes and funding.
Some of the biggest global pharmaceutical manufacturers have said lately that they are either pausing or scrapping operations in the UK, with some blaming the insufficient payments they are getting.
Last month, the government science advisor said the cost the health service pays for medicines would have to rise to halt companies and drug research funding leaving the UK.
The Chancellor told the BBC: "We have seen due to the cost structure, that drug testing, recent pharmaceuticals have not been provided in the UK in the manner that they are in other EU nations."
"The objective is to make sure that individuals receiving treatment from the NHS are able to receive the finest essential treatments in the globe. And so we are reviewing all of that, and... looking to secure additional capital into the UK."